Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
Schorlemmer
H U
HU
Research Laboratories of Hoechst Marion Roussel, Pharma Research Werk Kalle-Albert, Wiesbaden, Germany.
Kurrle
R
R
D000208:Acute Disease; D000480:Alkynes; D000818:Animals; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D007114:Immunization; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007519:Isoantigens / Q000096:biosynthesis; D007555:Isoxazoles / Q000494:pharmacology*; D000077339:Leflunomide; D017710:Lymphocyte Transfusion; D009570:Nitriles / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016038:Skin Transplantation / Q000276:immunology*; D013329:Structure-Activity Relationship; D013997:Time Factors; D014184:Transplantation, Homologous
D000480:Alkynes; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D007519:Isoantigens; D007555:Isoxazoles; D009570:Nitriles; C102911:X 910279; C115284:2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynamide; D000077339:Leflunomide